Clinical trials
Terminated Hyperglycemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 4 |
| 2008 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 7 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 2 |
| M.D. Anderson Cancer Center | 2 |
| Novartis Pharmaceuticals | 2 |
| Washington University School of Medicine | 2 |
| AstraZeneca | 1 |
| Atlantic Health System | 1 |
| Brigham and Women's Hospital | 1 |
| Children's Hospital Los Angeles | 1 |
| Eli Lilly and Company | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperglycemia | 27 |
| Diabetes Mellitus | 12 |
| Diabetes Mellitus, Type 2 | 6 |
| Hypoglycemia | 6 |
| Diabetes Mellitus, Type 1 | 4 |
| Insulin Resistance | 3 |
| Obesity | 3 |
| Breast Neoplasms | 2 |
| Hereditary Sensory and Autonomic Neuropathies | 2 |
| Lymphoma | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.